Our COVID Vaccine Statement and other related resources for patients and our researchers and research staff are available on the COVID-19 Updates webpage.
Dian Wang MD PhD
To determine the effect of reduced radiation volume through IGRT on > = Grade 2 lymphedema, subcutaneous fibrosis, and joint stiffness at 2 years from the start of radiation treatment
Data for this trial is being collected via the NRG/RTOG Data Center.
Histologically confirmed primary soft tissue sarcoma of the extremity; extraskeletal myxoid chondoscarcoma is eligible; sarcomas of the hand or foot are ineligible.
We are a leading protocol organizations within the National Clinical Trials Network and we seek to improve the lives of cancer patients by conducting practice-changing, multi-institutional clinical and translational research. Learn More
NRG Oncology Foundation, Inc, is a nonprofit, tax-exempt foundation. Donations to NRG Oncology help us conduct this important mission, and are tax-deductible to the extent permitted by law.